Evaluation of AChE inhibitors and dual AChE/GSK3-β inhibitor as Alzheimer’s disease treatment
Since the first patient affected by Alzheimer’s disease was reported in 1907, it became the worldwide leading cause of dementia. The disease is characterised by an initial accumulation of amyloid plaques, neurofibrillary tangles, along with cholinergic markers depletion. The currently available ther...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/64598/ |